126 related articles for article (PubMed ID: 38845248)
1. Prolongated and large dose of r-ATG relieves PD-L1 inhibitor-induced allograft rejection in liver transplant recipient.
Zhang YJ; Zhou DJ; Li H; Pan Q; Cheng Y
Hepatobiliary Pancreat Dis Int; 2024 May; ():. PubMed ID: 38845248
[No Abstract] [Full Text] [Related]
2. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
[TBL] [Abstract][Full Text] [Related]
4. Vascularized composite allograft rejection is delayed by infusion of IFN-γ-conditioned BMSCs through upregulating PD-L1.
Wang Y; Xi Y; Han F; Liu Y; Li N; Ren Z; Xue J; Guo L; Hu D
Cell Tissue Res; 2019 May; 376(2):211-220. PubMed ID: 30613905
[TBL] [Abstract][Full Text] [Related]
5. Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.
DeLeon TT; Salomao MA; Aqel BA; Sonbol MB; Yokoda RT; Ali AH; Moss AA; Mathur AK; Chascsa DM; Rakela J; Bryce AH; Borad MJ
J Gastrointest Oncol; 2018 Dec; 9(6):1054-1062. PubMed ID: 30603124
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
[TBL] [Abstract][Full Text] [Related]
7. Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States.
Riad S; Jackson S; Chinnakotla S; Verghese P
Pediatr Transplant; 2021 Aug; 25(5):e13928. PubMed ID: 33314638
[TBL] [Abstract][Full Text] [Related]
8. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.
Starke A; Lindenmeyer MT; Segerer S; Neusser MA; Rüsi B; Schmid DM; Cohen CD; Wüthrich RP; Fehr T; Waeckerle-Men Y
Kidney Int; 2010 Jul; 78(1):38-47. PubMed ID: 20393451
[TBL] [Abstract][Full Text] [Related]
10. Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation.
Kaiho T; Suzuki H; Hata A; Matsumoto H; Tanaka K; Sakairi Y; Motohashi S; Yoshino I
Front Pharmacol; 2023; 14():1298085. PubMed ID: 38026994
[TBL] [Abstract][Full Text] [Related]
11. Blockade or deficiency of PD-L1 expression in intestinal allograft accelerates graft tissue injury in mice.
Matsushima H; Morita-Nakagawa M; Datta S; Pavicic PG; Hamilton TA; Abu-Elmagd K; Fujiki M; Osman M; D'Amico G; Eguchi S; Hashimoto K
Am J Transplant; 2022 Mar; 22(3):955-965. PubMed ID: 34679256
[TBL] [Abstract][Full Text] [Related]
12. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
[TBL] [Abstract][Full Text] [Related]
13. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
14. An efficient combination immunotherapy for antitumor immunity without accelerating cardiac allograft rejection.
Miao X; Wu Z; Jiang Y; Liu H; Gong W
Immunology; 2023 Jun; 169(2):157-166. PubMed ID: 36517459
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
16. Programmed death-1 targeting can promote allograft survival.
Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
[TBL] [Abstract][Full Text] [Related]
17. Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration.
Lakhani L; Alasfar S; Bhalla A; Aala A; Rosenberg A; Ostrander D; Schollenberger MD; Brennan DC; Lipson EJ
Transplant Direct; 2021 Feb; 7(2):e656. PubMed ID: 33490381
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.
Aguirre LE; Guzman ME; Lopes G; Hurley J
Oncologist; 2019 Mar; 24(3):394-401. PubMed ID: 30413665
[TBL] [Abstract][Full Text] [Related]
19. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
[TBL] [Abstract][Full Text] [Related]
20. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
